Inherited mutations and a polymorphism in minK-related peptide 1 (MiRP1) have been linked to congenital or acquired long-QT syndrome, pointing to the importance of MiRP1 in maintaining the cardiac electrical stability. We tested whether MiRP1 could affect the function of Kv4.x (xϭ2 and 3), the major pore-forming (␣) subunits of transient outward (I to ) channels in the heart. We used the Xenopus oocyte expression system to examine the effects of MiRP1 on Kv4.x channel gating kinetics and current amplitude and correlated these effects with MiRP1 expression level. MiRP1 slowed the rates of Kv4.2 activation and inactivation and shifted the voltage dependence of channel gating in the positive direction. These effects had a similar "dose" dependence: they plateaued at a cRNA ratio (MiRP1:Kv4.2) of 13:1, with half-maximum effects at estimated cRNA ratios of 2 to 4. On the other hand, MiRP1 had no significant effects on Kv4.2 current amplitude in the same range of expression level. When expressed at a comparable low level, MiRP1 had similar (although smaller) effects on Kv4.3 but could not modulate Kv1.4 (another ␣ subunit of I to channels in the heart). Kv4.2 could be coimmunoprecipitated with epitope-tagged MiRP1, indicating that the 2 could form a stable complex. Our data suggest that MiRP1 may serve as a regulatory (␤) subunit of I to channels in the heart. This is supported by the observation that MiRP1 induced an "overshoot" of Kv4.2 current amplitude during channel recovery from inactivation, similar to the overshoot of I to described for human epicardial myocytes. (Circ Res. 2001;88:1012-1019.) 
method. 10 cRNAs were transcribed by using a commercial kit (mMessage mMachine), followed by DNase 1 digestion. All cRNA samples were run on a denaturing RNA gel and stained with ethidium bromide. The cRNA band sizes and intensities were quantified by use of densitometry (ChemiImager model 4400, Alpha Innotech Corp). The cRNA solutions were then diluted to reach the desired final concentrations for injections.
Oocyte Preparation and Injection
Oocyte isolation and cRNA injections were as described previously. 11 On the day of oocyte isolation (day 1), each oocyte was injected with 5 ng cRNA of Kv4.2 (or another ␣ subunit). On day 3, some oocytes were further injected with varying amounts of cRNA (1.5 to 79 ng) of MiRP1 (or another ␤ subunit). The molar ratios of cRNAs injected were calculated by dividing the nanogram amounts of cRNAs injected by the cRNA sizes.
Voltage-Clamp Experiments
On days 4 and 5, channel function was studied by using the 2-microelectrode voltage-clamp method, as described previously. 12 Oocytes were continuously superfused with a low-chloride ND96 solution at room temperature. Voltage-clamp protocol generation and data acquisition were controlled by pClamp 5.5 (Axon Instruments). Data analysis was performed with pClamp 6 or 8, Excel (Microsoft), and PeakFit (Jandel Scientific). Specific voltage-clamp protocols and methods of data analysis are described in the figure legends. Where appropriate, data are presented as meanϮSEM. Statistical analysis was performed with rank-based 1-way ANOVA followed by the Dunn test (SigmaStat 2.0, SPSS).
In Vitro Translation and Immunoprecipitation
In vitro translation of c-myc-tagged human MiRP1 and Kv4.2 was performed by use of a commercial kit (Rabbit Reticulocyte Lysate System, Promega) with canine pancreatic microsomes in the presence of [ 35 S]methionine. The 2 proteins were translated separately and then mixed. Immunoprecipitation of the translation products was carried out by using Immunopure Immobilized Protein G (Pierce) and an anti-c-myc monoclonal antibody (Oncogene) according to the manufacturer's instructions. The immunoprecipitates were fractionated on 10% SDS gel. After drying, the gel was exposed to a PhosphorImager (Molecular Dynamics) screen for an appropriate amount of time, followed by PhosphorImager quantification.
Results
In all experiments, oocytes were injected with the same amount (5 ng) of Kv4.2 cRNA and, 2 days later, varying amounts of human MiRP1 cRNA. The expression levels of MiRP1 are noted as MiRP1:Kv4.2 (cRNA molar ratio). Figure 1A illustrates 2 distinct effects of MiRP1 on Kv4.2: slowing of activation and slowing of inactivation. The changes in the activation kinetics were quantified by "timeto-peak" current (TTP) at ϩ60 mV. Data are summarized in Figure 1C . MiRP1 prolonged TTP of Kv4.2 in a "dose"dependent manner (from 5.1Ϯ0.1 ms in Kv4.2 alone to a maximum of 26.0Ϯ3.0 ms at an MiRP1:Kv4.2 cRNA molar ratio of 66:1), with the half-maximum effect occurring at an estimated cRNA ratio of 4. The inactivation of Kv4.2 during depolarization to ϩ60 mV followed an apparent doubleexponential function. To simplify data presentation and comparison, we quantified the data with the half-time of current decay, which is the time for current to decay to 50% of its peak value during a 1-second pulse to ϩ60 mV. Figure  1D shows that MiRP1 prolonged the decay half-time from 13.2Ϯ0.8 ms (Kv4.2 alone) to a maximum of 44.4Ϯ3.9 ms, with a dose dependence similar to that of its effect on TTP. Figure 1B shows that the Kv4.2 current amplitude measured at ϩ60 mV appeared to be increased modestly in the presence of MiRP1 at MiRP1:Kv4.2 cRNA molar ratios up to 13:1. However, the differences were not statistically significant. At a supramaximal level of MiRP1 expression (MiRP1:Kv4.2 66:1), there was a pronounced reduction in Kv4.2 current amplitude (to 54Ϯ6% of Kv4.2 alone). Effects of MiRP1 on Kv4.2 current amplitude and kinetics of activation and inactivation. A, Superimposed current traces were recorded at ϩ60 mV from oocytes expressing Kv4.2 alone or with MiRP1 (miRP1:Kv4.2 cRNA molar ratios marked). The display gain was adjusted so that peak current amplitudes match each other. B, MiRP1 had no statistically significant effects on Kv4.2 peak current amplitudes (measured at ϩ60 mV) except when expressed at an extremely high level (MiRP1:Kv4.2ϭ66:1). Data were from 2 batches of oocytes. For each batch, current amplitudes in oocytes coexpressing Kv4.2ϩMiRP1 (16 to 18 in each group) were normalized by the mean value from oocytes expressing Kv4.2 alone (*PϽ0.001 for Kv4.2ϩMiRP1 vs Kv4.2 alone). C, MiRP1 prolonged TTP of Kv4.2 current (measured at ϩ60 mV). The superimposed curve was calculated from the following equation: parameter (TTP)ϭA min ϩA max /(1ϩK/x), where A min is TTP in the absence of MiRP1 (4.9 ms), A max is the maximal TTP prolongation induced by MiRP1 (22.4 ms), and K is the MiRP1:Kv4.2 cRNA ratio that induced halfmaximum effect (4.4). D, MiRP1 prolonged the half-time of Kv4.2 decay (at ϩ60 mV). The superimposed curve was calculated as parameter (decay half-time)ϭA min ϩA max /(1ϩK/x), where A min is 13.1 ms, A max is 31.3 ms, and K is 2.4.
MiRP1 Affects Kv4.2 Gating Kinetics
MiRP1 also induced a dose-dependent positive shift in the voltage dependence of Kv4.2 activation ( Figure 2 ) and inactivation ( Figure 3 ). The dose dependence resembled those shown for the changes in gating kinetics in Figures 1C and  1D . On the other hand, MiRP1 did not alter the shape of the instantaneous current-voltage (I-V) relationship (Figure 2A ), indicating that it does not affect the ion permeation process of the Kv4.2 channel.
MiRP1 Retards 4AP Unbinding From Kv4.2 Channel
The above data suggest that MiRP1 can interact with Kv4.2 and hinder both the activation and the inactivation processes. The activation process of voltage-gated K ϩ channels involves conformational changes in the inner mouth region that result in the opening of the pore, allowing K ϩ ion fluxes through the channel. [13] [14] [15] The molecular mechanism of Kv4.2 inactivation is not entirely clear at present but likely also involves conformational changes in the inner mouth region. 16 Therefore, it is possible that at depolarized membrane voltages, the conformational changes in the inner mouth region of Kv4.2 are hindered by MiRP1. To test this hypothesis, we examined whether MiRP1 could affect the interaction between 4-aminopyridine (4AP) and Kv4.2. 4AP binds to the inner mouth region of Kv4.2 in the closed (resting) state at negative voltages. 17 Unbinding occurs at depolarized voltages when channels open and is further enhanced by channel inactivation. 18 According to our hypothesis, we predicted that 4AP unbinding from Kv4.2 should be hindered by MiRP1. Figure  4 shows the results of these experiments. The voltage-clamp protocol and rationale are described in the legend. The time course of 4AP (10 mmol/L) unbinding from Kv4.2 at ϩ60 mV could be described by a single exponential function both in the absence and in the presence of MiRP1. Consistent with our prediction, the value of 4AP unbinding was prolonged from 59Ϯ9 to 530Ϯ77 ms by MiRP1 (MiRP1:Kv4.2ϭ13:1).
MiRP1 Can Form a Stable Complex With Kv4.2
The above oocyte experiments indicate that MiRP1 could associate with Kv4.2 and modulate its function. Furthermore, because the MiRP1 cRNA was injected 2 days after Kv4.2 cRNA injection (at which time the Kv4.2 channel function had been well expressed), the association between MiRP1 and Kv4.2 did not require that the 2 be translated together. To further confirm these, we attached an epitope (c-myc peptide sequence EQKLISEEDL) to MiRP1, so that we could use an antibody to test whether MiRP1 and Kv4.2 could form a stable complex and be immunoprecipitated together. We inserted the c-myc sequence between amino acids 19 and 20 in the extracellular domain of MiRP1 (diagram in Figure 5A ), Figure 2 . A, MiRP1 had no effects on the instantaneous I-V relationship of Kv4.2. Voltage-clamp protocol (inset) was as follows: from V h of Ϫ80 mV, short pulses to ϩ90 mV for 4 ms (Kv4.2 alone) to 24 ms (with MiRP1) were used to activate currents to peak without appreciate decay. These were followed by repolarization steps (V r s) from ϩ80 to Ϫ50 mV in 10-mV steps. Current amplitudes 3 ms into V r were measured, leak-subtracted, and plotted against V r . To average data from different oocytes, current amplitudes in each cell measured at various V r levels were normalized to the level at V r ϩ80 mV. B, MiRP1 caused a positive shift in the peak I-V relationship of Kv4.2. Voltage clamp protocol (inset) was as follows: from V h of Ϫ80 mV, depolarization steps (V t s) for 250 ms from Ϫ50 to ϩ80 mV were applied once every 15 seconds. Peak currents were measured, leaksubtracted, and normalized to that at V t ϩ80 mV in the same oocytes (for data averaging). C, MiRP1 caused a positive shift in the voltage dependence of Kv4.2 activation. The activation curve was constructed in the following manner: for each oocyte, the peak current amplitudes at various V t levels were divided by the instantaneous current amplitudes measured at the same voltages (both without normalization). This gave an estimate of the fractions of channels activated at various V t levels. The relationship between y-axis (fraction activated) and x-axis (V t ) was fit with a simple Boltzmann function: fraction activatedϭ1/ {1ϩexp[(V t ϪV 0.5 )/k]}, which estimates the half-maximum activation voltage (V 0.5 ) and slope factor (k). D, Dose dependence of MiRP1-induced positive shift in V 0.5 of activation (nϭ17 to 27 each, from 6 batches of oocytes) is shown. The superimposed curve was calculated from A min ϩA max /(1ϩK/x), where A min is Ϫ7.3 mV, A max is 30.3 mV, and k is 1.8. Figure 3 . A, Effects of MiRP1 on the voltage dependence of Kv4.2 inactivation. Voltage-clamp protocol (inset in panel A) was as follows: from V h of Ϫ80 mV, conditioning pulses (V c s) were applied for 2 seconds to Ϫ90 to Ϫ20 mV in 5-mV increments. Each V c was followed by a test pulse (V t ) to ϩ60 mV. Peak current amplitudes during V t pulses after various V c levels were normalized to that after V c to Ϫ90 mV. This gave an estimate of fractions of channels available for activation after various V c levels. The relationship between fraction available and V c was fit close to the consensus N-glycosylation site (N26). The rationale was that if the interaction between MiRP1 and Kv4.2 occurs intracellularly, inserting the c-myc sequence in the extracellular domain should not interfere with the func-tion of MiRP1. Indeed, Figure 5A shows that the c-myctagged MiRP1 (c-myc-MiRP1) induced a prominent positive shift in the voltage dependence of Kv4.2 activation, similar to the effect of the unmodified MiRP1. Furthermore, c-myc-MiRP1 also slowed Kv4.2 activation and inactivation and delayed 4AP (10 mmol/L) unbinding from Kv4.2 at depolarized voltages.
The results of a representative immunoprecipitation experiment are shown in Figure 5B . c-myc-MiRP1 and Kv4.2 were in vitro-translated in separate reactions in the presence of [ 35 S]methionine. The translation products were then mixed and subjected to immunoprecipitation by an anti-c-myc monoclonal antibody. The immunoprecipitates were run on an SDS gel along with the Kv4.2 translation product. The autoradiogram clearly shows that Kv4.2 was copurified with c-myc-MiRP1 by the antibody (compare the left and right lanes of Figure 5B) . Similar results were obtained in 3 experiments. The middle lane of Figure 5B shows that coimmunoprecipitation of Kv4.2 with c-myc-MiRP1 was prevented by including a detergent (Triton X-100, 1%) in the immunoprecipitation reaction that could destabilize proteinprotein interactions. 19
MiRP1:Kv4.2 Interaction Is Preferred Over Other ␣:␤ Pairs
The above data, in conjunction with the known ability of MiRP1 to associate with HERG and modulate its function, 1 suggest that MiRP1 may be able to engage in promiscuous interactions with ␣ subunits of different gene families. To explore whether there is a preference in the interactions of MiRP1 with different ␣ subunits, we tested the effects of a low expression level of MiRP1 on various ␣ subunits (Kv4.2, Kv4.3, Kv1.4, and HERG). In all cases, MiRP1 cRNA was injected 2 days after ␣-subunit cRNA injections, and the cRNA molar ratios (MiRP1:␣ subunit) were kept at 2:1 except for HERG (MiRP1:HERGϭ6.6:1). Figure 6A shows that MiRP1 caused a positive shift in the inactivation curve of Kv4.3, similar to its effect on Kv4.2, although to a smaller degree. On the other hand, MiRP1 did not have detectable effects on Kv1.4. We also compared the effects of minK on Kv4.2 with those of MiRP1. At a low expression level (minK:Kv4.2 cRNA molar ratio 2:1), minK were as follows: experiments were performed in the continuous presence of 10 mmol/L 4AP. Double pulses (V 1 and V 2 ) each to ϩ60 mV were applied from V h of Ϫ80 mV once every 60 seconds (the long interval ensured a full development of 4AP binding before each V 1 ). The V 1 ϪV 2 interval was to Ϫ100 mV for 500 ms (to allow a full recovery of channels from inactivation without significant 4AP rebinding). The V 1 duration varied from 0 to 240 ms (Kv4.2 alone) or 0 to 2200 ms (Kv4.2ϩMiRP1) (to induce different degrees of 4AP unbinding). The growth of peak outward currents during V 2 then reflected the time course of 4AP unbinding during V 1 . A, Original current traces recorded from Kv4.2 alone or with MiRP1 (cRNA molar ratio 13:1). B, Time courses of 4AP unbinding from Kv4.2 at ϩ60 mV. Data were from the same experiments as in panel A. The fraction of 4AP unbound was calculated as (I t ϪI min )/(I max ϪI min ), where I min is peak amplitude during V 2 without V 1 , I max is peak amplitude during V 2 with longest V 1 , and I t is peak amplitude during V 2 with V 1 of "t" ms. The relationship between fraction unbound and V 1 duration was fit with a single exponential function to estimate of 4AP unbinding (78 and 458 ms for Kv4.2 and Kv4.2ϩMiRP1, respectively). C, Summary of of 4AP unbinding (nϭ4 and 5 for Kv4.2 and Kv4.2ϩMiRP1, respectively). *PϽ0.001. did not affect the voltage dependence of Kv4.2 inactivation or its gating kinetics. Figure 6B shows that MiRP1 had little or no effects on HERG current amplitude or gating kinetics (although the same level of MiRP1 expression induced significant changes in Kv4.2 gating kinetics).
MiRP1 Induced an Overshoot of Kv4.2 Peak Current Amplitude During Recovery From Inactivation
The voltage-clamp protocol and data analysis for studying the time course of Kv4.2 recovery from inactivation are described in the Figure 7 legend. Figure 7A shows that at a holding voltage (V h ) of Ϫ80 mV and a recovery interval of 2 seconds, Kv4.2 expressed alone completely recovered from inactivation (V 1 and V 2 current traces superimposed). However, when MiRP1 was coexpressed, the peak current amplitude during V 2 became significantly larger than that during V 1 ("overshoot"). Figure 7B depicts the complete time courses of changes in the V 2 current amplitude relative to that during V 1 in oocytes expressing Kv4.2 alone or coexpressing Kv4.2 with MiRP1 (MiRP1:Kv4.2ϭ2:1). The Kv4.2 current recovered from inactivation in a monoexponential function. On the other hand, in the presence of MiRP1, the V 2 current amplitude overshot that during V 1 , with a peak at V 1 ϪV 2 intervals of 1 to 3 seconds. MiRP1 also induced an overshoot of Kv4.3 peak current amplitude during recovery from inactivation (data not shown).
A similar overshoot phenomenon has been described for the I to channel in human ventricular myocytes of the epicardial origin. 20 The major ␣ subunit of I to channels in these myocytes is believed to be Kv4.3. 21 Interestingly, the I to channel in human ventricular myocytes from the endocardial region (whose major ␣ subunit is believed to be Kv1.4) 21 does not display such an overshoot phenomenon. 20 This distinction between epicardial and endocardial I to can be explained by our data: Kv4.x (xϭ2 or 3) can be modulated by MiRP1, whereas Kv1.4 cannot. To further compare the MiRP1induced overshoot in Kv4.2 with the I to overshoot in human epicardial myocytes, we examined the degree of overshoot measured at different V h s. In human epicardial myocytes, the degree of I to overshoot is enhanced by making the V h more negative, from Ϫ80 to Ϫ100 mV. 20 Figure 7C compares the peak levels of MiRP1-induced Kv4.2 overshoot measured at V h values of Ϫ80, Ϫ100, and Ϫ120 mV. As the V h became more negative, the overshoot peaked earlier (shorter V 1 ϪV 2 intervals) because the underlying rate of Kv4.2 recovery from inactivation became faster (ϭ743Ϯ52, 286Ϯ12, and 166Ϯ6 ms at Ϫ80, Ϫ100, and Ϫ120 mV). The peak level of overshoot at V h of Ϫ120 mV was significantly larger than that at V h of Ϫ80 mV.
The major ␣ subunit of I to channels in rat ventricle is Kv4.2. However, rat I to does not show an overshoot during restitution. To investigate whether this is due to differences between rat and human MiRP1 isoforms (18% differences in amino acid sequence), we compared the effects of rat MiRP1 on Kv4.2 restitution with those of human MiRP1. Figure 7D shows that rat MiRP1 induced little or no overshoot during Kv4.2 restitution.
Discussion
Our major findings can be summarized as follows: (1) 
Dose Dependence of Effects of MiRP1 on Kv4.2
Our data showed that MiRP1 modulated the Kv4.2 gating function in a dose-dependent manner. All the gating effects Figure 6 . A, Comparing potential I to channel ␣:␤ interactions by using voltage dependence of inactivation as an index. The ␣ subunits tested were Kv4.2, Kv4.3, and Kv1.4. The ␤ subunits tested were MiRP1 and minK. The ␤:␣ cRNA molar ratios were 2:1 in all cases. Voltage-clamp protocol and data analysis were as described in Figure 3 . B, MiRP1 had negligible effects on HERG at a cRNA molar ratio (MiRP1:HERG) of 6.6:1. Graph a shows voltage dependence of HERG activation; graph b shows normalized HERG current amplitude; and graph c shows value of HERG deactivation at Ϫ120 mV (nϭ5 to 8 for each group).
plateaued at an MiRP1:Kv4.2 cRNA molar ratio of 13:1 and were not increased further by elevating the ratio to 66:1. Therefore, the maximal effects of MiRP1 on Kv4.2 gating under our experimental conditions could be defined, although these data do not provide any information about the stoichiometry of MiRP1:Kv4.2. 22, 23 The similarity in the dose dependence of the effects of MiRP1 on Kv4.2 gating suggests common or closely related mechanisms. On the other hand, MiRP1 did not have statistically significant effects on the Kv4.2 current amplitude at cRNA ratios up to 13:1. Further elevating the cRNA ratio to 66:1 produced a prominent reduction in the Kv4.2 current amplitude, indicating that a different mechanism might be involved. Note that we injected the MiRP1 cRNA 2 days after the injection of Kv4.2 cRNA. In preliminary experiments, coinjecting MiRP1 and Kv4.2 cRNAs at the same time produced a marked suppression of Kv4.2 current amplitude even at a MiRP1:Kv4.2 ratio close to 2:1. It is possible that the much smaller MiRP1 cRNA (0.55 kb) could interfere with the biosynthesis processes of Kv4.2 cRNA (2.3 kb) in oocytes.
Many ␤ subunits known so far can increase the current amplitudes through channels formed by ␣ subunits with which they associate: minK on KvLQT1, 24 Kv ␤ subunits on Kv1, 25 KChIPs on Kv4, 9 and the K ϩ channel-associated protein (KChAP) on Kv2.1. 26 MiRP1 seems to be an exceptional case in this aspect. It has been shown that MiRP1 coexpressed with HERG in oocytes 1 or in mammalian cells 27 can significantly reduce the HERG current amplitude, although there is no consensus as to the mechanism. 1, 27 Our data highlight the importance of testing the effects of MiRP1 on different channel properties (eg, gating function versus current amplitude) at different expression levels and of using strategies (eg, separate cRNA injections) to minimize the potential interference of ␣-subunit biosynthesis by the small MiRP1 cRNA.
Mechanism of Effects of MiRP1 on Kv4.2: A Common Theme for Interactions Between KCNE ␤ Subunits and ␣ Subunits?
The best studied example of ␣-␤ interactions in Kv channels is minK/KvLQT1. 24, 28, 29 Our data show that the interaction between MiRP1 and Kv4.2 is similar to that between minK and KvLQT1 in the following aspects. First, MiRP1 slowed both the activation and the inactivation processes of Kv4.2, similar to the effects of minK on KvLQT1 gating. 24, 29 Second, because both the activation and the inactivation processes of Kv4.2 involve conformational changes in the inner mouth region of the pore 15, 16 and because the extracellular domain of MiRP1 did not seem to play a major role in its effects on Kv4.2 gating (inserting an epitope tag here did not affect its effects), it is possible that the cytoplasmic domain of MiRP1 interacts with the inner mouth region of Kv4.2. This is similar to the proposed domains of interactions between minK and KvLQT1. 28 Third, MiRP1 could associate with Kv4.2 and modulate its function even when the 2 were translated separately. This is similar to minK association with KvLQT1 28 but appears different from Kv ␤ association with Kv1 ␣ subunits (which occurs in the endoplasmic reticulum when both proteins are being translated in proximity). 25 
Does MiRP1 Association With Kv4.x Recapitulate the Native I to Function?
It is well established that Kv4.x (xϭ2 and/or 3) are the major ␣ subunits of I to channels in the heart. 7 However, there are still distinct differences in the behavior between Kv4.x expressed in mammalian cells or Xenopus oocytes and native I to channels in cardiac myocytes, suggesting that an additional factor(s) or subunit(s) is required to recapitulate the native I to channel function. For example, under comparable recording conditions (in terms of temperature and the ionic composition of bath solution), the voltage dependence of activation and inactivation of native I to channels occurs in a more positive voltage range than that of Kv4.x in heterologous expression systems. 30 MiRP1 can shift the voltage dependence of Kv4.x gating in the positive direction, thus making Kv4.x more Figure 7 . Time course of Kv4.2 recovery from inactivation in the absence and presence of MiRP1. Voltage-clamp protocol (inset in panel A) was as follows: from V h of Ϫ80, Ϫ100, or Ϫ120 mV, double pulses (V 1 and V 2 ) each to ϩ40 mV for 500 ms were applied once every 15 seconds. The V 1 ϪV 2 (recovery) interval ranged from 5 to 12 000 ms. Degree of recovery was measured by normalizing the peak current amplitude during V 2 to that during V 1 (V 2 /V 1 ). A, Representative V 1 and V 2 current traces recorded from Kv4.2 expressed alone or with MiRP1 (MiRP1:Kv4.2ϭ66:1). V h was Ϫ80 mV, and V 1 ϪV 2 interval was 2000 ms. In the presence of MiRP1, the peak current during V 2 overshot the peak current during V 1 . B, Complete time courses of changes in V 2 /V 1 against V 1 ϪV 2 interval (plotted on a logarithmic scale). Shown are meanϮSEM from 3 oocytes expressing Kv4.2 alone and 3 oocytes coexpressing Kv4.2 and MiRP1. V h was Ϫ80 mV. C, Degrees of MiRP1-induced overshoot of V 2 current amplitude at different V h levels. Shown are peak levels of overshoot (represented by V 2 /V 1 Ͼ1) at V h of Ϫ80 mV (measured at V 1 ϪV 2 ϭ3 seconds), Ϫ100 mV (V 1 ϪV 2 ϭ1 second), and Ϫ120 mV (V 1 ϪV 2 ϭ0.8 second). For comparison, the V 2 /V 1 values from oocytes expressing Kv4.2 alone are also shown. D, At a comparable cRNA molar ratio (MiRP1:Kv4.2ϭ7:1), the rat isoform (rMiRP1) induced much less Kv4.2 overshoot than did the human isoform (hMiRP1). V h was Ϫ80 mV, and V 1 ϪV 2 interval was 2 seconds (nϭ5 to 9 for each group). *PϽ0.001, Kv4.2ϩhMiRP1 vs Kv4.2 alone.
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similar to the native I to . Furthermore, the I to in human ventricular myocytes of epicardial origin displays a peculiar overshoot phenomenon during recovery from inactivation (V 2 current was larger than V 1 current by Ϸ30%). 20 This is not seen when Kv4.x is expressed alone. MiRP1 coexpression with Kv4.x could reproduce this phenomenon: the current during V 2 overshot the current during V 1 by Ϸ20%. The degree of MiRP1-induced Kv4.2 overshoot was increased by shifting the V h from Ϫ80 to Ϫ120 mV, similar to the voltage dependence of I to overshoot in human epicardial myocytes. 20 However, the human I to overshoot peaks at a V 1 ϪV 2 interval of 100 to 200 ms, whereas the MiRP1-induced Kv4.2 overshoot in oocytes peaked at 1000 to 2000 ms under similar conditions (V h Ϫ80 mV and room temperature). It is possible that other subunit(s), such as KChIP, may be also involved in determining the native I to kinetics. 9 Indeed, Figure 8 supports this notion.
Implications of Our Findings
The present data suggest that MiRP1 has the potential of serving as a regulatory (␤) subunit of native I to channels in cardiac myocytes. However, to test this hypothesis, one needs a reliable MiRP1 antibody that can detect the expression and location of MiRP1 protein in cardiac myocytes. On the other hand, MiRP1 is expressed at a much higher level in the brain and may affect the native I to channels there. We showed that when tested in oocytes at a low expression level, MiRP1 appears to preferentially modulate the gating function of Kv4.x (more for Kv4.2 than for Kv4.3) over HERG or Kv1.4. It is not clear whether this preference in MiRP1 actions is due to the oocyte expression environment. Future experiments should test whether this phenomenon can be reproduced in mammalian cells. In cardiac myocytes, the importance of interactions between different ␣ and ␤ subunits may depend on the expression levels and other factors (eg, subcellular distribution, subunit trafficking, and clustering). It will be important to sort out these selection processes and understand whether and how these processes are affected by mutations of channel (␣ or ␤) subunits and by disease conditions of the heart. This information will enhance our understanding of the molecular basis for the heterogeneity of Kv channel function in normal and in diseased hearts. 
